Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

SELL
$50.45 - $72.82 $1.24 Million - $1.79 Million
-24,632 Reduced 56.95%
18,618 $978,000
Q1 2023

May 04, 2023

SELL
$51.25 - $79.34 $717,500 - $1.11 Million
-14,000 Reduced 24.45%
43,250 $2.77 Million
Q4 2022

May 23, 2023

BUY
$46.82 - $76.2 $655,480 - $1.07 Million
14,000 Added 32.37%
57,250 $2.78 Million
Q3 2022

Nov 03, 2022

SELL
$70.55 - $111.58 $51,783 - $81,899
-734 Reduced 1.27%
57,250 $4.04 Million
Q2 2022

Aug 04, 2022

BUY
$50.24 - $80.48 $102,439 - $164,098
2,039 Added 3.64%
57,984 $4.11 Million
Q1 2022

May 05, 2022

BUY
$57.98 - $93.5 $40,296 - $64,982
695 Added 1.26%
55,945 $4.47 Million
Q3 2021

Nov 10, 2021

SELL
$122.75 - $162.68 $626,025 - $829,668
-5,100 Reduced 8.45%
55,250 $7.1 Million
Q2 2021

Aug 06, 2021

BUY
$105.76 - $154.96 $126,912 - $185,952
1,200 Added 2.03%
60,350 $9.2 Million
Q1 2021

May 10, 2021

BUY
$78.5 - $126.48 $404,275 - $651,372
5,150 Added 9.54%
59,150 $6.24 Million
Q4 2020

Feb 08, 2021

SELL
$55.93 - $82.78 $6.15 Million - $9.11 Million
-110,041 Reduced 67.08%
54,000 $4.28 Million
Q3 2020

Nov 12, 2020

BUY
$45.65 - $61.81 $1.09 Million - $1.48 Million
23,900 Added 17.05%
164,041 $9.28 Million
Q1 2020

May 12, 2020

BUY
$25.01 - $42.4 $662,765 - $1.12 Million
26,500 Added 23.32%
140,141 $4.52 Million
Q4 2019

Feb 06, 2020

BUY
$24.55 - $38.13 $2.79 Million - $4.33 Million
113,641 New
113,641 $4 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.11B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.